United States · FDA National Drug Code directory
UPLIZNA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75987-150_ec8e46bc-7edf-405d-8c8e-2b2f7042fcb5
- Product NDC
- 75987-150
- Form
- INJECTION
- Composition / generic term
- Inebilizumab
- Labeler
- Horizon Therapeutics USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200611
- Source listing expiry
- 20261231
Source-listed ingredients
- INEBILIZUMAB — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01) · 75987-150-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →